OXERVATE
Dompe' Farmaceutici S.p.a.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79205724 |
| Registration Number | 5357221 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
| Attorney Name | Elizabeth Brenckman |
| Attorney Docket Number | 363810024US1 |
| Law Office Assigned | L70 |
| Employee Name | TRUSILO, KELLY JEAN |
Timeline
| 2016-12-27 | Application Filed |
| 2017-10-03 | Published for Opposition |
| 2017-12-19 | Location: PUBLICATION AND ISSUE SECTION |
| 2017-12-19 | Status: Live/Registered |
| 2017-12-19 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  DOMPE' FARMACEUTICI S.P.A. |
| Address | Via San Martino della Battaglia, 12 I-20122 MILANO IT |
| Legal Entity Type | Joint Stock Company |
| Legal Entity State | IT |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 010905 | Molecular models; Atomic models |
| 260102 | Circles, plain single line; Plain single line circles |
| 261701 | Bands, straight; Bars, straight; Lines, straight; Straight line(s), band(s) or bar(s) |
| 261705 | Bands, horizontal; Bars, horizontal; Horizontal line(s), band(s) or bar(s); Lines, horizontal |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| CC0000 | Color is not claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2017-04-20 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-04-28 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-04-28 | 3 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2017-05-02 | 4 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2017-05-05 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2017-05-06 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2017-05-12 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2017-05-12 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2017-06-03 | 9 RFNT P: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2017-07-26 | 10 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2017-07-26 | 11 ARAA I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2017-08-22 | 12 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2017-08-22 | 13 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-08-22 | 14 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2017-08-22 | 15 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-08-22 | 16 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-09-13 | 17 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2017-10-03 | 18 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-10-03 | 19 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2017-12-19 | 20 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2018-03-19 | 21 FICR P: |
| FINAL DISPOSITION PROCESSED | 2018-03-28 | 22 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2018-03-28 | 23 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2018-05-12 | 24 FINV P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-02-12 | 25 NREP P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2021-06-04 | 26 ADCH M: |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2022-12-19 | 27 REM3 E:E-Mail |
| TEAS SECTION 71 & 15 RECEIVED | 2023-12-06 | 28 ES75 I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OXERVATE 79205837 5352715 Live/Registered |
DOMPE' FARMACEUTICI S.P.A. 2016-12-27 |
 OXERVATE 79205724 5357221 Live/Registered |
DOMPE' FARMACEUTICI S.P.A. 2016-12-27 |
 OXERVATE 79170436 4868952 Live/Registered |
Dompé farmaceutici S.p.A. 2015-05-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 